scholarly article | Q13442814 |
P50 | author | Parizad Avari | Q89691580 |
P2093 | author name string | Petros Perros | |
Colin Dayan | |||
Ben Williams | |||
Vickie Lee | |||
British Oculoplastic Surgery Society (BOPSS) and TEAMeD | |||
P2860 | cites work | Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. | Q34010116 |
Assessing quality of life in Australian patients with Graves' ophthalmopathy | Q35591594 | ||
Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone | Q35592595 | ||
Orbital decompression for Graves' orbitopathy in England | Q35820372 | ||
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy | Q36811289 | ||
Quality of life in thyroid eye disease: impact of quality of care | Q37849042 | ||
Treatment options for Graves' orbitopathy | Q37992118 | ||
Evaluating Graves' orbitopathy | Q38013209 | ||
What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review. | Q38223449 | ||
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists. | Q38285063 | ||
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement. | Q38692635 | ||
Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit | Q38906232 | ||
Public health relevance of Graves' orbitopathy | Q43428269 | ||
The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey | Q43579038 | ||
Incidence of hyperthyroidism in Sweden | Q46963719 | ||
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience | Q47945181 | ||
The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of Life | Q47952058 | ||
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. | Q49360067 | ||
Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial. | Q49360082 | ||
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways | Q62000454 | ||
Management of patients in a combined thyroid eye clinic in secondary care | Q62000474 | ||
A questionnaire survey on the management of Graves' orbitopathy in Europe | Q79988590 | ||
Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients | Q82793494 | ||
The Amsterdam Declaration on Graves' orbitopathy | Q83056514 | ||
Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis | Q84148014 | ||
Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method | Q88407827 | ||
P921 | main subject | United Kingdom | Q145 |
eye disease | Q3041498 | ||
P577 | publication date | 2019-12-13 | |
P1433 | published in | Eye | Q10278937 |
P1476 | title | A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom |
Search more.